Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:receptor_tyrosine_kinase
gptkb:drug |
| gptkbp:administeredBy |
oral
|
| gptkbp:CASNumber |
943319-70-8
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:developedBy |
Arog Pharmaceuticals
|
| gptkbp:hasMolecularFormula |
C26H27FN6O
|
| https://www.w3.org/2000/01/rdf-schema#label |
crenolanib
|
| gptkbp:investigatedBy |
gptkb:acute_myeloid_leukemia
gastrointestinal stromal tumors |
| gptkbp:molecularWeight |
458.53 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
CP-868596
|
| gptkbp:target |
gptkb:PDGFR
gptkb:FLT3 |
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:PDGFR
gptkb:PDGFRα |
| gptkbp:bfsLayer |
6
|